You've built the science.
We'll help build the business.

With an impressive career spanning over two decades, Peter has established himself as a trusted and experienced commercial leader in the life science research and diagnostics markets. His tenure includes commercial senior leadership roles at prestigious organizations such as Roche, Illumina, and Integrated DNA Technologies (Danaher), where he led product management, product marketing and growth marketing initiatives for molecular biology solutions in translational research, clinical diagnostics, and drug development.

Known for his strategic foresight and passion for understanding customer needs, Peter has masterfully developed and executed new product introduction (NPI) and go-to-market (GTM) strategies for over 35 innovative products in the life sciences and diagnostics arenas grossing more than $500M.

Scott boasts over twenty years of extensive experience across various commercial departments, encompassing Service & Support, Sales, Marketing, and Operations. Throughout his tenure at Illumina, Scott emerged as a pivotal figure, spearheading over 20 successful product launches and establishing three distinct functions: Sales Enablement, Financial Services, and a Program Management Office.

His proficiency spans from intricate scientific and technical understanding to orchestrating top-tier strategies and execution in Marketing, Sales, Commercial Operations, and Corporate Strategy.

Gwen is an award-winning health care communications professional who provides public relations, corporate communications, reputation management, policy communication, and public affairs assistance to large corporations, startups, and non-profit organizations. Her clients are innovators seeking to push the boundaries of what's possible across the continuum from biomedical research to clinical care.

Gwen has held in house communications roles with Element Biosciences, BD, Illumina, and Personalized Medicine Coalition, where she honed her deep focus on how communications activities can support business objectives.

Aruna brings 20+ years of healthcare sector experience, specializing in strategic decision-making and boosting ROI. She excels in offering actionable insights to life science companies, leading problem-solving initiatives through analysis and recommendation synthesis.

Previously, she contributed to Illumina's market insights team, conducting analyses for executives, marketing, investor relations, and sales. Prior to that, she served as a strategy consultant at Scientia Advisors, focusing on life science strategies.

Megan Kane is a regulatory and quality leader who helps medical device and life science organizations build compliance into simple, scalable processes.

With expertise spanning Class I–III medical devices, in vitro diagnostics, and AI-powered SaMD, she has led global submissions and designed quality management systems for FDA, Health Canada, EU MDR/IVDR and TGA requirements.

Megan believes that when documentation is easy to maintain and regulatory strategies are crystal clear, compliance can become a powerful tool for growth rather than a barrier.

Specializing in genomics and biotechnology, Tyler is adept in both research and business development, including revenue modeling and product development. As the Director of Capital Development and Partnerships at Biocom California, he has skillfully facilitated partnerships with biotech startups to secure critical funding.

Previously, as Senior Director of Pharma Alliances North America at SOPHiA GENETICS and Associate Director at Thermo Fisher Scientific, Tyler honed his expertise in patient-focused data decisions and built strategic alliances in oncology diagnostics and therapeutics.

His dedication to innovation has consistently driven successful partnerships across the life sciences industry.